| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.28 | 5e-08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 8e-06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.009 |